| NCT ID | NCT05842629 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Aarhus |
| Condition | Ovarian Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,700 participants |
| Start Date | 2021-05-15 |
| Primary Completion | 2024-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,700 participants in total. It began in 2021-05-15 with a primary completion date of 2024-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
After implementation of systematic image description of adnexal masses, we aim to improve and evaluate our use of available imaging methods and biomarkers for classifying adnexal masses and distinguishing between benign and malignant adnexal masses in the hands of clinicians in Central Denmark Region. Secondarily, we want to improve our management of adnexal masses by evaluating the complications and longitudinal changes in conservatively managed adnexal masses. Data is registered prospectively but analyzed retrospectively.
Eligibility Criteria
Patients with an adnexal mass observed at ultrasonography.
Contact & Investigator
Ina Marie Dueholm Hjorth, MD
PRINCIPAL INVESTIGATOR
University of Aarhus
Frequently Asked Questions
Who can join the NCT05842629 clinical trial?
This trial is open to female participants only, studying Ovarian Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05842629 currently recruiting?
Yes, NCT05842629 is actively recruiting participants. Contact the research team at imhjorth@gmail.com for enrollment information.
Where is the NCT05842629 trial being conducted?
This trial is being conducted at Aarhus, Denmark.
Who is sponsoring the NCT05842629 clinical trial?
NCT05842629 is sponsored by University of Aarhus. The principal investigator is Ina Marie Dueholm Hjorth, MD at University of Aarhus. The trial plans to enroll 1,700 participants.